Literature DB >> 8432504

Cocaine use by schizophrenic outpatients who receive depot neuroleptic medication.

A M Stone1, R A Greenstein, G Gamble, A T McLellan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432504     DOI: 10.1176/ps.44.2.176

Source DB:  PubMed          Journal:  Hosp Community Psychiatry        ISSN: 0022-1597


× No keyword cloud information.
  6 in total

Review 1.  Organizational guidelines for dual disorders programs.

Authors:  C C Mercer; K T Mueser; R E Drake
Journal:  Psychiatr Q       Date:  1998

2.  Accuracy of self-report, biological tests, collateral reports and clinician ratings in identifying substance use disorders among adults with schizophrenia.

Authors:  Sarah L Desmarais; Richard A Van Dorn; Brian G Sellers; M Scott Young; Marvin S Swartz
Journal:  Psychol Addict Behav       Date:  2012-12-31

3.  Temporal discounting of rewards in patients with bipolar disorder and schizophrenia.

Authors:  Woo-Young Ahn; Olga Rass; Daniel J Fridberg; Anthony J Bishara; Jennifer K Forsyth; Alan Breier; Jerome R Busemeyer; William P Hetrick; Amanda R Bolbecker; Brian F O'Donnell
Journal:  J Abnorm Psychol       Date:  2011-08-29

Review 4.  The bipolar patient with comorbid substance use disorder: recognition and management.

Authors:  Mark J Albanese; Ronald Pies
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

5.  Letter to the editor: Critique of Bahorik et al. (2013)--'Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors'.

Authors:  Richard A Van Dorn; Sarah L Desmarais; Marvin S Swartz; M Scott Young; Brian G Sellers
Journal:  Psychol Med       Date:  2013-10-28       Impact factor: 7.723

Review 6.  Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence.

Authors:  P A LeDuc; G Mittleman
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.